Recently, the research team led by Prof. SHEN Huahao and Prof. YING Songmin from the Key Laboratory of Respiratory Disease of Zhejiang Province, Department of Respiratory and Critical Care Medicine of SAHZU, discovered that eosinophilic inflammation promotes metastatic tumor growth. This study offers a potential target for the therapy of metastatic disease. The findings were published in the journal Science Advances on May 26.
June 17, SAHZU Neurosurgeon Prof. LIU Fengqiang remotely manipulates the stereotactic neurosurgery robot, Remebot, 200 kilometers away in Songyang Hospital of Li Shui City through a 5G network, and evacuates the intracerebral hematoma of a patient there. This remarkable achievement set a milestone of establishing China's first 5G-based digital neurosurgery operating theater.
May 20 Thursday, a team of SAHZU vascular surgeons and endocrinologists arrive at Chen Jia Pu, a traditional village 300 kilometers southwest of Hangzhou located in the mountains of Li Shui city's Song Yang county, to offer free medical consultations for the villagers there.
On May 10, Asia Pacific Forum on Global Health-Through and Beyond the Pandemic was held online and offline in Hangzhou, bringing together more than 400 physicians, researchers, global health experts, educators, students from 29 universities in 13 countries and regions.
Epilcure™, the country's first closed loop neurostimulation system developed by Prof. ZHANG Jianmin, Chair of SAHZU Neurosurgery, Prof. ZHU Junmin, Vice Chair of SAHZU Neurosurgery, and their team, is proved to be effective after one month’s follow-up since its first implantation on March 18.
The lecture series will serve as a platform to showcase cutting-edge research from leading physicians and scientists, for an audience of clinicians, research faculty, postdoctoral fellows, and graduate students from cardiovascular research communities at SAHZU, UCLA and beyond.
Physicians, researchers, global health experts, policy makers, educators are welcomed to share ideas and exchange knowledge at the one-day hybrid event, to further explore what we can contribute to advance human health through innovative discovery, education and health care to address big challenges facing the human beings in the Post-Pandemic Era.
SAHZU and Keqiao district government of Shaoxing, a city 50km southeast of Hangzhou, sign an agreement to jointly build the Keqiao campus, the newest piece of SAHZU map, Tuesday afternoon.
The result of 2019 Chinese National Tertiary Hospital Performance Evaluation is revealed Tuesday March 30. SAHZU is accredited as an A++ hospital again and ranks 7th out of 2413 Chinese public tertiary hospitals, two positions up from previous year. Besides siting in the top rank in the country, SAHZU also leads in the province as it's the only Zhejiang hospital that ranks top 10 in China in two consecutive years.
Mar 24 9am, A blood-delivering drone lands slowly on the blood station of SAHZU's Binjiang Campus. With QR code scanning by medical staff, the container carried by the drone present itself to the deliver window. Inside are three packets of blood dispatched from the Zhejiang Provincial Blood Center.
Italian surgeons Drs. Michele Cricrì and Federico Mongardini and Mexican surgeon Dr. Mitre Reyes have recently completed a three-month clinical training program at SAHZU Colorectal Surgery, as the second group of trainees of International Colorectal Surgery Training Academy of China (ICSTAC).
Dr. Lim Shin Hoei is an anesthesiologist from Penang, Malaysia. She was trained at SAHZU for trans-esophageal echocardiogram (TEE) and cardiothoracic anesthesia for six months. Congratulation to Dr. Lim!
Dr. Sujai Nikhil from India has finished a three month training at SAHZU focusing on interventional cardiology procedures and structural heart problems. Watch what he has gained from this program!